Plasmodium vivax malaria: Is it actually benign?

SummaryPlasmodium vivax (Pv) malaria is being increasingly recognized as a cause of severe malaria in children.ObjectivesTo describe the various severe manifestations associated with vivax malaria by retrospective analysis of records.MethodsChildren between the ages of 0 and 18 years with a confirmed diagnosis of Pv malaria monoinfection done by peripheral blood film (PBF) and/or rapid diagnostic test (RDT) admitted between June and September 2009 were included. Their clinical, hematological and biochemical manifestations were analyzed.ResultsTwenty-three patients of Pv malaria were retrospectively analyzed. Thrombocytopenia was present in 22 (96%) patients with counts less than 50,000/μL in 9 patients. Severe anemia (hgb<5mg/dl) was present in 8 (34%) patients. Cerebral malaria was present in 3 patients. Liver enzymes were elevated (>3 times normal) in 4 (17.3%) patients while jaundice (bilirubin>2.5mg/dl) was present in 2 patients (total bilirubin 5.2mg/dl and 14.3mg/dl). Renal dysfunction (creatinine>3mg/dl) was present in 6 (26%) patients with 2 patients showing severely deranged renal functions (blood urea 168mg/dl, 222mg/dl and serum creatinine 5.0mg/dl, 5.6mg/dl, respectively). Hypernatremia was present in one patient. One patient expired within 12h of presentation because of severely deranged hepatic and renal dysfunction.ConclusionPv malaria can lead to unusual and fatal complications. All new guidelines should include “Severe Vivax malaria” as a clinical entity. Further research into the etiopathogenesis and treatment would be important